Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.56M Buy
12,604
+150
+1% +$51.3K 2.18% 9
2026
Q1
$4.38M Sell
12,454
-365
-3% -$130K 2.14% 11
2025
Q4
$4.2M Sell
12,819
-969
-7% -$307K 2.14% 11
2025
Q3
$3.89M Buy
13,788
+160
+1% +$46.4K 2.1% 9
2025
Q2
$3.81M Buy
13,628
+367
+3% +$104K 2.21% 11
2025
Q1
$4.13M Buy
13,261
+613
+5% +$181K 2.46% 3
2024
Q4
$3.3M Buy
12,648
+356
+3% +$106K 2.14% 13
2024
Q3
$3.96M Sell
12,292
-485
-4% -$159K 2.61% 4
2024
Q2
$3.99M Sell
12,777
-734
-5% -$216K 2.85% 3
2024
Q1
$3.84M Sell
13,511
-75
-0.6% -$21.9K 2.7% 4
2023
Q4
$3.91M Sell
13,586
-302
-2% -$82.3K 2.98% 4
2023
Q3
$3.95M Sell
13,888
-190
-1% -$47.4K 3.45% 2
2023
Q2
$3.21M Buy
14,078
+275
+2% +$63.8K 2.82% 9
2023
Q1
$3.34M Buy
13,803
+532
+4% +$131K 3.04% 6
2022
Q4
$3.49M Buy
13,271
+19
+0.1% +$5.09K 3.17% 2
2022
Q3
$2.99M Sell
13,252
-235
-2% -$57K 2.97% 6
2022
Q2
$3.28M Buy
13,487
+131
+1% +$32.1K 3% 4
2022
Q1
$3.41M Buy
13,356
+1,248
+10% +$287K 2.78% 8
2021
Q4
$2.72M Buy
+12,108
New +$2.56M 2.43% 11

Other funds holding AMGN

Apricus Wealth's AMGN Position: Q2 2026 in Review

Apricus Wealth increased its Amgen (AMGN) stake by 1.2% in Q2 2026, buying an estimated $51.3K and bringing the position to 12,604 shares worth $4.56M. The position accounts for 2.18% of the portfolio, ranked #9.

Apricus Wealth first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. 1,171 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Apricus Wealth held 12,604 shares of Amgen worth $4.56M as of Q2 2026.
  • Apricus Wealth bought 150 Amgen shares in Q2 2026, an estimated $51.3K.
  • Amgen made up 2.18% of Apricus Wealth's portfolio in Q2 2026, its #9 holding.
  • Apricus Wealth first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
  • 1,171 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Apricus Wealth's 13F filing for Q2 2026, filed 22 Jul 2026.